Cavinton vinpocetine tablet, drug treatment, benefit and side effects
Cavinton is the name for vinpocetine used by researchers in Russia, Bulgaria, and eastern European countries. Cavinton has shown some promise for stroke related conditions. Cavinton improves blood flow to the brain, ear, and eyes. The optimal Cavinton dosage for various medical conditions is not fully known. Most studies have used dosages of 10 mg three times daily, but Cavinton side effects could occur on these dosages. We suggest you first begin taking vinpocetine at 5 mg a day and then monitor your progress, benefits, and side effects over a few days before increasing or decreasing your dosage. Potential Cavinton side effects include dizziness, lightheadedness, malaise, and weakness.
Vinpocetine 5 mg and 10 mg per capsules
Vinpocetine 5 mg and 10 mg
Vinpocetine capsule has been sometimes recommended
for more than once daily however many people may be sensitive to this supplement
and would do fine using half a capsule. Always start your first time with half a 5 mg vinpocetine pill
in order to see if you have any negative responses to it. By taking a small
amount of vinpocetine at first, you could avoid a vinpocetine side effect.
Click here to purchase or for additional details on this Vinpocetine product
Cavinton for eyes
Effect of vasoactive agents on visual functions and
ocular blood flow in patients with early manifestations of age-related macular
degeneration.
Vestn Oftalmol. 2007 May-Jun;123(3):26-8.
Forty patients aged 40 to 65 years who had non-exudative forms of age-related
macular degeneration (AMD), including 20 patients with degeneration of the
retinal pigment epithelium (RPE), 15 with retinal drusen, and 5 with RPE atrophy
were examined. All the patients were divided into 2 groups. Group 1 comprised 20
patients receiving, in addition to conventional therapy, cavinton forte (1
tablet contains 10 mg of vinpocetine). Group 2 (control) included 20 patients
receiving conventional therapy (antioxidants, peptide bioregulators, lutein containing
agents). Medical treatment was performed during 2 months. After a course of cavinton therapy, patients with AMD were observed to have better visual acuity,
improved retinal function, and increased a- and b-wave amplitudes on a macular
electroretinogram. There was improvement of ocular blood flow values, which is
indicative of better uveal blood supply.
Cavinton for cerebral
insufficiency
Cavinton forte treatment of cerebral vascular insufficiency in patients with
coronary heart disease and arterial hypertension
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(7):31-4. Protasov KV,
Dzizinskii( AA, Shprakh VV, Sinkevich DA, Kuklin SG, Filatova LN.
Using 48-h Holter monitoring of ECG and ambulatory blood pressure monitoring, 28
patients (13 men, 15 women, mean age 66 years) with cerebral vascular
insufficiency of the I-II stage in combination with chronic coronary heart
disease and essential arterial hypertension were examined. Quantitative
parameters of myocardial ischemia episodes and hypotension conditions were
calculated and compared before the beginning (the first 24 h of monitoring) and
during taking the daily dose of 30 mg of Cavinton forte (the second 24 hours of
monitoring). The distribution of ischemia and hypotension episodes in the
periods of the maximal supposed effect of the drug was analyzed. Cavinton forte
neither contributes to the manifestation and average frequency of myocardial
ischemia episodes nor influences parameters and the character of short-term
arterial hypotension episodes. The drug reduces quantity and duration of blood
pressure nocturnal fall. It is concluded that initial Cavinton forte treatment
of cerebral vascular insufficiency in patients with chronic coronary heart
disease in combination with arterial hypertension is safe when combined with
hemodynamically active antihypertensive and antiischemic therapy.
Cavinton for hearing loss
Cavinton prevention of neurosensory hypoacousis in patients with different forms
of tuberculosis
Vestn Otorinolaringol. 2003;(3):35-40. Maliavina US, Ovchinnikov IuM,
Fasenko VP, Maliev BM, Kalinina MV, Dadasheva BB.
According to pharmacological studies, cavinton has an effect on the end links of
aminoglycosides interaction with elements of the internal ear. Basing on this
property, cavinton was used as prophylaxis of neurosensory hypoacusis in 118
patients aged 17 to 63 years suffering from tuberculosis. The results of the
studies have shown than cavinton not only prevents hypoacusis in patients with
normal hearing but also improves it in patients with hearing problems.
Cavinton for menopause symptoms
Complex effects of cavinton on climacteric symptoms
Akush Ginekol (Sofiia). 2001;42(2):37-41. Kolarov G, Orbetsova M, Nalbanski
B, Kamenov Z, Georgiev S, Filipov E, Petrova Iu, Marinov B, Georgiev G.
The aim of the present study is to assess the therapeutic effect of Cavinton (vinpocetin)
on the degree of climacteric symptoms and to verify its complex beneficial
influence. The study comprises of three groups of women in early
menopause--control group (n = 30), treatment groups with normolipidaemia and
with hyperlipidaemia. All women presented with moderately expressed climacteric
symptoms as assessed by Kupperman menopausal index and Hamilton-Anxiety-Skala (HAMA).
The women in the 2nd and 3rd groups have been taking Cavinton in an oral dose of
5 mg three times daily for 3 months. Our data suggest that Cavinton possesses
complex beneficial effects in climacteric women significantly ameliorating
climacteric symptoms as well as some parameters of lipid metabolism in women
with hyperlipidemia.
Is it okay to take Cavinton along with a
bacopa monnieri pill?
First find out how each one makes you feel and then when
combining use smaller amounts of each supplement.